Irish medtech firm Neuromod raises €30m to expand tinnitus treatment

The firm plans to expand into the US Market following FDA Approval and the establishment of its wholly owned US subsidiary

Founded in 2010, Neuromod will also expand the availability of Lenire to additional European countries, including Italy, the Netherlands, Portugal, and Sweden

Irish medtech company Neuromod Devices has raised €30m to expand its treatment for tinnitus across the US and Europe.

Neuromod's device, Lenire, has been approved by the US Food and Drud Administration (FDA) for treating tinnitus in the US Market.